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ARTICLE
FoxG1 regulates the formation of cortical
GABAergic circuit during an early postnatal critical
period resulting in autism spectrum disorder-like
phenotypes
Goichi Miyoshi 1✉, Yoshifumi Ueta1, Akiyo Natsubori 2, Kou Hiraga 1, Hironobu Osaki 1, Yuki Yagasaki1,
Yusuke Kishi 3, Yuchio Yanagawa4, Gord Fishell5,6,7, Robert P. Machold5 & Mariko Miyata 1
Abnormalities in GABAergic inhibitory circuits have been implicated in the aetiology of
autism spectrum disorder (ASD). ASD is caused by genetic and environmental factors.
Several genes have been associated with syndromic forms of ASD, including FOXG1. How-
ever, when and how dysregulation of FOXG1 can result in defects in inhibitory circuit
development and ASD-like social impairments is unclear. Here, we show that increased or
decreased FoxG1 expression in both excitatory and inhibitory neurons results in ASD-related
circuit and social behavior deficits in our mouse models. We observe that the second
postnatal week is the critical period when regulation of FoxG1 expression is required to
prevent subsequent ASD-like social impairments. Transplantation of GABAergic precursor
cells prior to this critical period and reduction in GABAergic tone via Gad2 mutation ame-
liorates and exacerbates circuit functionality and social behavioral defects, respectively. Our
results provide mechanistic insight into the developmental timing of inhibitory circuit for-
mation underlying ASD-like phenotypes in mouse models.
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ASDs are characterized by social communication deficitsand restricted/repetitive behavioral patterns (DSM-5),with a prevalence around 1–2% of all children (USA: CDC
estimate). While the vast majority of ASDs are thought to emerge
through a combination of genetic and environmental risk factors,
a percentage (~5%) of ASD cases are syndromic, in that they are
caused by highly penetrant mutations in a single gene, such as
MECP2 (Rett or duplication), FMR1 (Fragile X) or SHANK3
(Phelan-McDermid)1. Despite their relative rarity, these syn-
dromic forms of ASD have provided key insights into the broader
etiological basis of ASD. Of particular interest, many syndromic
ASD models show an increase in the cortical synaptic excitation-
inhibition (E/I) ratio, a phenomenon that has been hypothesized
to underlie the cognitive and behavioral symptoms of ASD2,3.
Inhibition mediated by cortical GABAergic interneurons is
known to regulate animal social behaviors4 and abnormal
GABAergic signaling has been implicated in both schizophrenia
and ASD2,3,5,6. Loss of inhibitory neurons has been observed in
postmortem ASD patient studies7 and consistent with this, chil-
dren with ASD are more likely to have epilepsy. In ASD modeling
studies, conditional mutations of syndromic ASD genes in
GABAergic populations often reproduce the ASD phenotypes
found in the respective null animals8,9. Developmentally,
GABAergic systems are known to regulate circuit plasticity and
are capable of accelerating or delaying the onset of the visual
critical period10. Furthermore, transplantation of GABAergic
neuronal precursors has been shown to induce plasticity in the
mature visual cortex11. However, how GABAergic circuit dys-
function during development contributes to adult ASD pheno-
types is still not well understood. Indeed, the elevated cortical
excitatory-inhibitory ratio observed in syndromic ASD models
has been recently reported not to reflect network hyperexcitability
per se, but rather is a homeostatic compensation of synaptic drive
in the adult circuits12. Thus, investigating how perturbations in
inhibitory circuit development contribute to the etiology of ASD
should help innovate therapeutic approaches.
Recently, FOXG1, a critical transcription factor for forebrain
development13–21 has been linked to ASD and other neurode-
velopmental disorders such as schizophrenia22. Studies in patient-
derived iPS cells have suggested that FOXG1 dysregulation
broadly contributes to the etiology of idiopathic ASD23. Fur-
thermore, perturbation of FOXG1 has been implicated in a new
type of syndromic ASD (FOXG1 syndrome), with gene duplica-
tions (gain-of-function)24,25 or loss-of-function mutations (het-
erozygous haploinsufficiency)26–29 observed in affected
patients30–32. Moreover, recent advances in sequencing techni-
ques have revealed FOXG1 point-mutations in idiopathic ASD
children (FOXG1 Research Foundation), suggesting that there are
more undiscovered FOXG1 syndrome patients world-wide.
However, both when during development and in which brain
circuits FOXG1 dysregulation contributes to ASD etiology have
not been elucidated.
Here we demonstrate that neuronal FoxG1 dysregulation pre-
cipitates ASD-related social impairments in our mouse models
when FoxG1 expression changes are paired in both excitatory and
inhibitory populations. We find that the second postnatal week is
a critical period for developing ASD phenotypes upon FoxG1
dysregulation. Indeed, at the end of this critical period, the cor-
tical excitatory-inhibitory ratio is already imbalanced in all three
variants of FoxG1 Low and High ASD models. We show that the
GABAergic system plays pivotal roles during the critical period
by demonstrating that weakening or supplementing cortical
GABAergic tone exacerbates or ameliorates the social behavioral
impairments of the FoxG1 ASD model, respectively. We thus
identify both the critical time-window and inhibitory circuit
mechanisms that lead to ASD-related social behavioral
impairments upon FoxG1 dysregulation. Our results support the
promise of therapeutic approaches to ameliorate ASD phenotypes
through the early intervention of cortical GABAergic systems.
Results
A rodent FOXG1 syndrome model exhibiting ASD-like social
behavioral impairments. In order to address the developmental
circuit mechanisms underlying the social behavioral alterations
found in ASD patients, we first examined if ASD
FOXG1 syndrome could be recapitulated in rodents to model the
disease phenotypes. We utilized the three-chamber assay to test
for ASD-related unconditioned social behaviors4,8,33–37 in FoxG1
Heterozygous adult animals (6 weeks old)13. In this behavioral
assay, animals are first allowed to freely explore the three
chambers connected by corridors (Fig. 1a, Habituation). Next, an
age and gender-matched stranger wild type mouse is introduced
in a cage located in one chamber, allowing the test animal to
make a choice between exploring a chamber with a novel mouse
versus an empty cage (Fig. 1a, Sociability). In the third session,
preference of the test animal to explore the chamber with an
already familiar mouse versus the chamber with a newly intro-
duced stranger mouse is compared (Fig. 1a, Social Novelty). As
expected, wild type animals spent a significantly increased
amount of time in the social side of the chambers in both
sociability (Fig. 1b, open orange bar) and social novelty assays
(filled orange bar). However, FoxG1 Heterozygous animals
showed no obvious preference for the social side of the chamber
(Fig. 1b, left versus right chamber) and instead spent a sig-
nificantly increased amount of time in the center chamber
(Fig. 1b, compare filled purple bars of Nov), suggesting decreased
sociability, consistent with ASD-like social behavioral deficits.
Indeed, the sociability score was found to be decreased in the
FoxG1 Heterozygous animals (Fig. 1c, scored based on the orange
bar graphs in 1b).
We carried out a battery of additional behavioral analyses of
this FoxG1 Heterozygous mouse model to test whether there were
other behavioral abnormalities beyond the impairments in
contextual fear memory reported previously38. Briefly, while
general motor functions of the Heterozygous animals were
comparable to the controls (Fig. 1d), Heterozygous animals
showed decreased anxiety (Fig. 1e) and impairments in working
memory (Fig. 1f).
Neither the loss of GABAergic cells nor microcephaly per se
causes ASD social phenotypes in FoxG1 haploinsufficient ani-
mals. Haploinsufficient FOXG1 syndrome ASD patients exhibit
microcephaly27,28, and likewise, reduction in the size of the cer-
ebral hemispheres has been reported in at least three different
FoxG1 Heterozygous mouse models38–40 and was observed here
(Fig. 2a, b). In addition, consistent with the cases reported in ASD
postmortem studies7, we further found a reduction in GABAergic
neuron numbers within the medial prefrontal (prelimbic and
infralimbic) and somatosensory barrel cortices in these animals
(Fig. 2d–g, k). We hypothesized that the microcephaly phenotype
is due to the role of FoxG1 in progenitor proliferation within the
developing forebrain18,19,41,42. We thus preserved FoxG1
expression in progenitors (Fig. 2c) by utilizing Cre drivers for
postmitotic glutamatergic (Nex-Cre)43 and GABAergic (Dlx-
Cre)44 neurons of the forebrain and used them in conjunction
with one copy of a conditional loss-of-function FoxG1 allele20
(Fig. 2l). Indeed, in this postmitotic neuronal Heterozygous
model, both cortical thickness as well as GABAergic cell density
were rescued to levels comparable to control animals in both
medial prefrontal and somatosensory barrel cortices (Fig. 2h–k).
Importantly, this neuronal postmitotic FoxG1 haploinsufficiency
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model also spares glial FoxG1 expression45–47 unlike the Het-
erozygous model (Fig. 2c).
We first asked if neuronal FoxG1 haploinsufficiency is
sufficient to reproduce the ASD-phenotypes observed in FoxG1
Heterozygous animals (Fig. 2m, Glu+GABA Low, traces in
Supplementary Fig. 1). Indeed, FoxG1 haploinsufficiency in both
pyramidal and GABAergic neurons led to social behavioral
impairments in a manner comparable to the Heterozygous model
(Fig. 1b). This suggests that neither microcephaly nor loss of
GABAergic cells causes social behavioral impairments per se. We
next asked if ASD-related social behavioral deficits originate from
excitatory or inhibitory circuit mechanisms upon removal of one
copy of FoxG1. Reduction of FoxG1 levels in postmitotic
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Low). GABA Low littermate animals unexpectedly exhibited an
increased preference for social novelty, with animals spending
significantly more time in chambers containing mice in
comparison to controls (Fig. 2m, GABA Low, orange asterisks).
Thus, our results indicate that in FOXG1 haploinsufficiency ASD
patients, reduced sociability is due to FOXG1 hypofunction in
both excitatory and inhibitory postmitotic neurons.
ASD phenotypes in haploinsufficient and duplication
FOXG1 syndrome models arise from paired FoxG1 changes in
both excitatory and inhibitory neurons. Increased FOXG1 gene
copy number can also result in ASD symptoms24,25; thus, we
sought to examine how FoxG1 gain-of-function could affect social
behavior. Considering that FoxG1 gain-of-function can disrupt
the migration of pyramidal neurons20, we chose to augment
FoxG1 levels during the early postnatal period after most neu-
ronal migration is complete (~1st postnatal week; P7)48. We again
utilized Cre drivers specific for excitatory and inhibitory lineages
in the forebrain, here combined with a conditional transactivator
line (R26-stop-tTA) and a transactivator-dependent FoxG1
expression allele (TRE-FoxG1), and FoxG1 gain-of-function was
initiated only after P7 (Fig. 3a). Using the three-chamber assay,
we found that animals exhibited social behavioral deficits only
when FoxG1 is augmented in both Glu+GABA lineages simul-
taneously (Fig. 3b, traces in Supplementary Fig. 2). This outcome
in the sociability scores is similar to that observed upon reduction
of FoxG1 expression (Fig. 3c), albeit with a milder phenotype in
social novelty sessions compared to the Heterozygous (Fig. 1b) or
neuronal Glu+GABA Low models (Fig. 2m). In sum, we con-
clude that either up- or downregulation of FoxG1 expression
levels impairs social behavior, but only when the perturbation
occurs in both excitatory and inhibitory populations (Fig. 3c,
purple bars).
Upon establishing three ASD FOXG1 syndrome models of
Heterozygous, Low (neuronal Glu+GABA Low) and High
(1 week Glu+GABA High), in addition to the social behavioral
evaluations, we cross-correlated other behavioral features and
cortical EEG patterns. In contrast to the FoxG1 Heterozygous
animals (Fig. 1f), no working memory deficits were observed in
FoxG1 Low and High models (Fig. 3d, see also Supplementary
Fig. 3). FoxG1 Heterozygous animals are often aggressive, and
attack siblings or partners during mating, but these behaviors
were also not evident in the Low and High models. In addition,
no clear anxiety phenotype was observed in the FoxG1 Low and
High models in the open field and elevated plus maze assays
(Fig. 3e, f, see also Supplementary Figs. 1 and 2). These results
indicate that working memory impairment, aggression or anxiety
does not account for the social behavior abnormalities observed
in our FoxG1 Low and High perturbation models.
We next tested if the gamma-band frequency of EEG is
attenuated in a manner similar to ASD patients49,50 or in rodent
models4,51,52. We performed EEG recordings during the awake
free-moving state with the electrodes aligned nearby the medial
prefrontal cortex (Fig. 3g to j, Supplementary Fig. 4). In the
control 8 weeks old wild type mice, the power spectrum peak in
the high-frequency range was found nearby 58 Hz (Fig. 3k,
orange trace). However, this peak was reduced as well as shifted
to a lower frequency range in the Heterozygous model (Fig. 3k,
black trace), with peak amplitude reduced in the Low model
(Fig. 3k, gray trace), or the peak shifted to lower frequency in the
High model (Fig. 3k, blue trace), resulting in overall reduction in
high-gamma frequency power (55–80 Hz) in these socially
impaired FoxG1 models (Fig. 3l). While epilepsies have been
observed in some human FOXG1 syndrome patients24,26–28,30,31,
we did not detect any obvious epileptic behavior in any of our
FoxG1 perturbation models.
In order to verify the expected alterations in FoxG1 expression
in our socially impaired FoxG1 mutant models, we measured the
FoxG1 protein levels within the medial prefrontal cortex at
postnatal 2 and 6 weeks by western blotting (Fig. 3m–o). By
removing one copy of FoxG1, FoxG1 protein levels were reduced
to approximately half of that in the control animals in both
Heterozygous and Low models (Fig. 3o). This result indicates that
a compensatory upregulation of FoxG1 mRNA transcription
likely does not occur in haploinsufficient FOXG1 patients either.
Already at postnatal 2 weeks, FoxG1 High manipulation at 1 week
was sufficient to increase FoxG1 protein levels to that observed in
6-week old animals (Fig. 3o). We further validated our gain-of-
function method by confirming that the increase of FoxG1 is
suppressed by continuous feeding of doxycycline (Fig. 3o, +Dox).
We conclude that our genetic strategies enabled precise
manipulations in FoxG1 protein levels in our model animals.
An early juvenile ASD critical period identified through tem-
poral FoxG1 dysregulation and imbalanced excitatory-
inhibitory circuits. While excess copy number of FOXG1 has
been identified in syndromic forms of ASD, the ectopic upregu-
lation of FOXG1 expression has been suggested to be a key
contributor to disease etiology in idiopathic ASD patients23. We
thus took advantage of our doxycycline-repressible gain-of-
function system (Fig. 3a) and carried out FoxG1 High (Glu+
GABA) manipulations during selective postnatal time-windows
(Fig. 4a). When FoxG1 augmentation is delayed for 2 weeks
(Fig. 4a, 3w High), instead of 1 week (Figs. 4a and 3b), this no
longer resulted in social behavioral impairments (Fig. 4a),
demonstrating that FoxG1 augmentation per se does not affect
animal social behavior. Thus, we performed FoxG1 augmentation
exclusively between 1 and 3 weeks by replacing the doxycycline
diet with a regular one only during this period and found that
these animals (1–3w High) showed alterations in sociability to a
similar extent as 1 week High animals (Fig. 4a, scores compared
in Fig. 4b). We further carried out FoxG1 augmentation between
1 and 2 weeks or 2–3 weeks (Fig. 4a, 1–2w and 2–3w High) and
discovered that between 1 and 2 weeks is the critical time-window
for FoxG1 augmentation (Fig. 4b). Western blotting analysis
revealed that the changes in FoxG1 protein levels occur within
Fig. 1 The FOXG1 syndrome Heterozygous model mouse displays ASD-like social behavioral impairments. a–c Representative traces of animal location
of wild type and FoxG1 Heterozygous (LacZ knock-in) littermates are shown for each 10min of the Habituation, Sociability, and Social Novelty sessions (a).
Social behavior of the animals was analyzed by comparing the time spent in each chamber of the three-chamber assay (b). Social behavior scores of the
animals are calculated based on the time spent at the social side (orange bars in b) of the chambers (c, p= 0.00753**). Wild type animals preferred to
spend time in the social side of the chambers (b, orange bar graphs) while Heterozygous animals did not exhibit a social preference (b, purple * and NS for
left vs. right chamber bar graphs). WT: n= 26, p= 0.261(Hab), p= 2.55 × 10−7****(Soc), p= 4.90 × 10−5**** (Nov), Het: n= 26, p= 0.911(Hab), p=
0.0117*(Soc), p= 0.262(Nov). In addition, Heterozygous animals preferred the middle chamber (filled purple bar graph, p= 0.00759**) in the third social
novelty session and avoided the two lateral chambers harboring other mice. d–f Other behavioral paradigms tested: Heterozygous animals showed normal
locomotion (d, n= 14 each), mildly decreased anxiety (e, n= 14 each, p= 0.0334*) and reduced working memory (f, n= 28 each, p= 0.000180***). Data
are mean ± SEM, p values are from two-tailed t-test.
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2 days upon addition or removal of the doxycycline-containing
diet (Supplementary Fig. 5d).
Upon identifying a critical period for FoxG1 dysregulation, we
hypothesized that there would be a shared circuit deficit found
across all three FoxG1 ASD models particularly during this time-
window. To this end, we evaluated excitatory-inhibitory (E/I)
balance by performing slice electrophysiological recordings of
mEPSC and mIPSC events in layer 2/3 pyramidal neurons of the
medial prefrontal cortex (prelimbic and infralimbic, Fig. 4c, right)
in our three ASD FOXG1 syndrome models of Heterozygous,
Low (neuronal Glu+GABA Low) and High (1 week Glu+
GABA High). Upon examining 2-week old juvenile animals, we
found that the E/I ratio within the medial prefrontal cortex was
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Fig. 2 ASD FOXG1 syndrome social phenotypes are due to neuronal FoxG1 haploinsufficiency, but not microcephaly or loss of GABAergic cells. a, b
Consistent with the microcephaly phenotypes found in human FOXG1 haploinsufficiency patients, Heterozygous animals (b) exhibit a smaller brain size and
reduced GABAergic cell numbers (labeled by Dlx5a-Cre; Ai9) compared to wild type (a). Blue brackets indicate the thickness of the barrel cortex in wild
type animals. c In the neuronal FoxG1 Heterozygous model, FoxG1 haploinsufficiency only takes place in postmitotic neurons, thus sparing the progenitors
and glia of the neocortex. d–i In situ hybridization with a Gad1 antisense probe (black) labels GABAergic cell populations, with DAPI stain (blue) to visualize
the laminar structure of the cortex in Control (d, e), FoxG1 Heterozygous (f, g) and the postmitotic neuronal Heterozygous model (h, i: Nex-Cre; Dlx-Cre;
FoxG1-C/+, scheme in l). In the Heterozygous model, the cortical thickness of the S1 Barrel (g) but not the mPFC (f) is reduced compared to the Control
(d, e). Removal of one copy of FoxG1 selectively in postmitotic neuronal populations rescues the Heterozygous microcephaly phenotype (h–j). While
GABAergic cell density is reduced in both the mPFC and S1 Barrel cortex of the Heterozygous model (f, g) compared to the Control (d, e), this phenotype
was completely rescued in Neuronal Het animals (h, i, k). j, k The thickness of cortical layers 1–6 (j) as well as Gad1-positive cell density (k) were analyzed.
Control: n= 4, FoxG1 Het: n= 6(mPFC) or 4(S1BF), Neuronal Het: n= 4, Control vs. Het: p= 0.0945 (j: mPFC),=0.00398**(j: S1),= 0.0377* (k: mPFC),
= 0.0276*(k: S1), Control vs. Neuronal Het: p= 0.909,= 0.101,= 0.613,= 0.463 (same order with Het). l, m Genetic strategy (l) and results from three-
chamber social interaction experiments of FoxG1 Low model (m). For the sake of clarity, in the bar graphs (m), the first 10 min of habituation data is not
included (see the full data sets in Supplementary Fig. 1). m Neuronal Het animals without any microcephaly or GABAergic cell loss phenotypes showed
ASD-like social behavioral impairments similar to the Heterozygous model (Fig. 1a–c). This was not the case in either Glu Low or GABA Low models and
unexpectedly, GABA Low models showed a strong preference for the social side of the chamber (orange asterisks) during the social novelty session. Data
are mean ± SEM, p values are from two-tailed t-test.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23987-z ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:3773 | https://doi.org/10.1038/s41467-021-23987-z | www.nature.com/naturecommunications 5
surprise, and distinct from other rodent ASD models12, we found
no obvious change in the E/I balance within the adult medial
prefrontal cortex in our FoxG1 ASD models (Fig. 4f–h). In fact,
not just the E/I ratio but the values for the mEPSC and mIPSC
were comparable to that of controls (Fig. 4g, h). The exception
was a slight decrease in the E/I frequency ratio in the
Heterozygous medial prefrontal cortex due to a reduced mEPSC
frequency (Fig. 4g), although this was not the case in the barrel
field (Supplementary Fig. 6). These data suggest that, in our

































































































Soc Nov Soc Nov








































HetWT Low HighCtrl Ctrl
FoxG1
ß-actin
2w mPFC 6w mPFC











c d e f
m n o
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23987-z
6 NATURE COMMUNICATIONS |         (2021) 12:3773 | https://doi.org/10.1038/s41467-021-23987-z | www.nature.com/naturecommunications
imbalanced E/I ratio within the juvenile medial prefrontal cortex
normalizes by adult ages, this results in permanent circuit
changes as indicated by altered gamma EEG power (Fig. 3l) and
impaired social behavior (Fig. 3c).
Decreased GABAergic activity exacerbates ASD social pheno-
types in the FOXG1 syndrome model. In the FoxG1 Hetero-
zygous model, the E/I ratio in the cortical circuit is transiently
increased immediately after the critical period (Fig. 4d). We thus
hypothesized that this model precipitates ASD phenotypes
through a decrease in inhibitory GABAergic tone. In order to test
this, we first addressed the roles of GABAergic transmission for
the development of ASD phenotypes by analyzing Gad2 mutant
animals53,54 in the three-chamber assay (Fig. 5a). In contrast to
its isoform Gad1, Gad2 predominantly resides at presynaptic
terminals to synthesize GABA locally. Thus, removal of the Gad2
gene effectively reduces overall GABAergic synaptic tone and its
loss has been shown to modify the visual critical period10,55. In
the three-chamber sociability assay, while we found no obvious
changes in the Gad2 heterozygotes (Fig. 5b), Gad2 nulls did not
show a preference for the social side of the chamber (Fig. 5b, NS
purple). During the social novelty session, although Gad2 null
animals still preferred the chamber with a novel animal, they
spent more time in the center chamber (Fig. 5b, purple asterisks)
and thus their overall sociability score was reduced (Fig. 5d).
These data suggest that the reduction of GABAergic tone in Gad2
nulls leads animals to develop ASD-like social behavioral
impairments. Interestingly, the social behavior score of the Gad2
nulls was decreased to a level comparable to the FoxG1 Hetero-
zygous model (Fig. 5d purple bars).
We next analyzed the consequence of reducing GABAergic
transmission in the FoxG1 Heterozygous background by cross-
comparing the Gad2 littermate animals (Fig. 5c, d). In the FoxG1
Heterozygous background, both Gad2 heterozygous and null
animals showed no preference to the novel animal (Fig. 5c) and
preferred the center chamber in the social novelty session
(Fig. 5c), suggesting that they exhibit ASD-like social impair-
ments. Moreover, both Gad2 heterozygous and null mutations
further reduced the sociability score of the FoxG1 Heterozygotes
(Fig. 5d dark bars). We further found that reduction of
GABAergic tone does not affect the working memory of the
animals (Fig. 5e) in contrast to the sociability (Fig. 5d). These data
suggest that reducing GABAergic tone exacerbates the social
behavioral alterations found in the ASD FoxG1 haploinsufficiency
mouse model. This further supports the idea that the FoxG1
Heterozygous model develops ASD phenotypes through altera-
tions in GABAergic systems during the early juvenile critical
period.
Augmentation of GABAergic systems during the juvenile cri-
tical period re-balances the cortical E/I ratio and ameliorates
the social impairments of the FoxG1 ASD model. In the
FOXG1 syndrome haploinsufficiency model, cortical inhibition is
reduced during the critical period (Fig. 4d, e), and further
attenuation of GABAergic tone exacerbated the social impair-
ments of this model (Fig. 5). We thus hypothesized that a proper
E/I ratio during the early juvenile critical period is important for
the development of ASD phenotypes, and that augmentation of
GABAergic tone during this period might re-adjust the E/I
imbalance and improve the behavioral outcomes of FoxG1 Het-
erozygotes. In order to test this, we focused on the mPFC, a brain
region implicated in social behavior4, and we took advantage of
the GABAergic cell precursor transplantation technique. This
method has been shown in several contexts to therapeutically
modify recipient mature neural circuits by transplanted donor
cells forming new inhibitory synapses and creating circuit
plasticity11,56–58. We dissociated EGFP-labeled GABAergic cell
precursors (Dlx-Cre; RCE:loxP59,60) from the E13.5 medial
ganglionic eminences (MGE) that are wild type for FoxG1,
bilaterally transplanted these cells into the postnatal 1 week
medial prefrontal cortices, and analyzed E/I ratios at 2 weeks of
age (Fig. 6a, scheme). When the miniature frequencies of mPFC
layer 2/3 cells were analyzed one week after the transplantation
(Fig. 6b), we found that the increased E/I ratio in the Hetero-
zygous animals was rescued to wild type levels upon receiving
GABAergic neuron precursor transplantation (Fig. 6c, NS in
orange). Consistent with this, GABAergic precursor transplan-
tation did not attenuate the peak amplitude E/I ratio of the
Heterozygous models (Fig. 6d), suggesting that GABAergic cell
precursor transplantation at one week normalized the excitatory-
inhibitory local circuit balance in the Heterozygous animal model
to levels comparable to wild type. We further confirmed that the
Fig. 3 ASD social phenotypes arise from a balanced decrease or increase of FoxG1 in excitatory and inhibitory populations. a–c A genetic strategy for
the ligand-inducible FoxG1 augmentation High model (a) and results from three-chamber social interaction experiments (b, c and see the full data sets in
Supplementary Fig. 2). Only the Glu+GABA High model exhibited a clear social behavioral alteration, with milder phenotypes observed during the social
novelty session (b). A summary diagram of the social behaviors of FoxG1 Het (Fig. 1b), Low (Fig. 2m) and High (b) models (c). In order to cross-correlate
the animal models for two different social assays, time spent in the novel side of the chamber during the sociability session (orange bar) was multiplied to
the time spent outside the center chamber during the social novelty session (orange bars). The models with ASD-like social behavioral alterations are
colored in purple. Data are normalized to the values of the controls within each group. d–f Other behavioral paradigms tested on the Low (Glu+GABA)
and High (Glu+GABA) models. Unlike the Heterozygous animals (Fig. 1f), both Low (n= 68, control n= 62) and High (n= 34, control n= 48) models
show no clear deficits in working memory (d). Both Low (n= 34, control n= 31) and High (n= 17, control n= 24) models show normal locomotion (e),
and Low model displayed mildly decreased anxiety (f, p= 0.00181**), in a manner similar to the Heterozygous animals (Fig. 1e). Please see Supplementary
Figs. 1–3 for the complete data analysis. g–j EEG recording was carried out in awake freely behaving adult (7–8 weeks) wild type (n= 4) and littermate
FoxG1 Heterozygous (n= 6) animals and was compared to Low (n= 5) and High models (n= 3). Representative examples of raw (top) and filtered high-
gamma frequency traces (bottom). k, l Normalized power spectrum in medium to high-frequency ranges are shown (k). Note that power line noise at 50
Hz is masked. The peak at high-frequency range in the wild type (54.5–58.5 Hz) was significantly reduced in the Heterozygous and Low models (p=
0.00568** and= 0.0143*). This peak was shifted toward low-frequency range in the High model (k). EEG high-gamma frequency power relative to the
wild type animals is shown as bar graphs for the FoxG1 Heterozygous (p= 0.00254**), Low (p= 0.0466*) and High models (l). See Supplementary Fig. 4
for the theta and low-gamma frequency analysis.m–o FoxG1 protein levels in the mPFC was analyzed in the FoxG1 Heterozygous, Low and High models and
compared to the control animals by using western blotting (m, n, see the full data sets in Supplementary Fig. 5). FoxG1 levels are reduced to approximately
half in the Heterozygous and Low, and increased 1.3 times in the High model at postnatal 2 and 6 weeks (o). We confirmed that continuous doxycycline
(Dox) feeding effectively suppresses FoxG1 augmentation. n= 3 each, except for 2wWT and Het n= 6. Data are mean ± SEM, p values are from two-tailed
t-test.
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rescue of E/I balance at 2 weeks in Heterozygotes upon
GABAergic cell precursor transplantation restores the E/I balance
to normalcy in adulthood (Fig. 6e, f).
We next tested if correcting the E/I balance of the mPFC at two
weeks would rescue the adult ASD-like social behavioral
impairments of the Heterozygous animals. In the three-
chamber assay (Fig. 6g and j), GABAergic cell transplantation
into wild type animals did not overtly affect the sociability of the
animals at 6 weeks and was comparable to non-transplanted wild
type (Fig. 1b) or other control animals (Figs. 2m and 3b). When
FoxG1 Heterozygotes received GABAergic cell precursors into the
mPFC at postnatal 1 week (Fig. 6a and h), the animals spent
comparable time in the social side of the chamber to the controls
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novelty sessions, cell-transplanted Heterozygotes preferred the
stranger side (Fig. 6j, asterisks in orange) as well as spent
comparable time in the center chamber to the controls (Fig. 6j,
NS in orange). These data suggest that re-balancing the E/I ratio
of the mPFC at 2 weeks (Figs. 6c, d) by GABAergic cell precursor
transplantation allows FoxG1 Heterozygous animals to recover
from the ASD-like socially impaired state. Furthermore, this is
consistent with the notion that FoxG1 must be simultaneously
disrupted in both excitatory and inhibitory populations to
precipitate ASD behavioral phenotypes (Fig. 3c), since the
transplanted GABAergic cells are wild type for FoxG1. Next, in
order to test the importance of correcting the circuit E/I ratio at
postnatal 2 weeks, we further carried out GABAergic cell
transplantation at 3 weeks, instead of 1 week (Fig. 6i). We found
that the social behavioral phenotypes of the late-transplanted
Heterozygous animals at 6 weeks are distinct from the 1 week-
transplanted wild type or Heterozygous animals (Fig. 6g–j) and
are comparable to the non-transplanted Heterozygotes (Fig. 1b,
scores in Supplementary Fig. 7e). This was consistent even later at
8 weeks (Supplementary Fig. 7f), upon matching the differentia-
tion period of the donor cells to the postnatal 1 week
transplantation experiments. These data further support our
notion that between postnatal 1–2 weeks of age is the critical
time-window to mitigate ASD-related social phenotypes. When
working memory was tested, cell transplanted Heterozygotes did
not show obvious improvements compared to the non-
transplanted Heterozygotes (Fig. 6l, NS), suggesting that
GABAergic cell precursor transplantation into the mPFC
selectively ameliorates the social-related modality but not the
general working memory deficits of the Heterozygous model.
Altogether, we conclude that precisely regulated FoxG1
expression levels during early juvenile development is crucial,
and dysregulation of FoxG1 expression during this period results
in a transient perturbation of E/I balance, resulting in ASD-like
gamma EEG patterns as well as social behavioral deficits in adult
animals. For the ASD FOXG1 syndrome haploinsufficiency
model, in which local inhibitory tone is decreased during the
early juvenile critical period, a decrease in GABAergic activity
exacerbates the social behavior deficits, whereas re-balancing the
E/I ratio by enhancing GABAergic tone ameliorates the social
impairments (Fig. 6k, scores compared), thus pinpointing this
developmental stage as promising for therapeutic intervention.
Discussion
The developing brain possesses a remarkable resilience to genetic
and/or environmental insults, and has the intrinsic means to
adjust its functional properties by scaling excitatory and
inhibitory neuronal activity through homeostatic regulation12. It
has been hypothesized that neurocognitive disorders such as ASD
arise when the brain’s capacity to buffer the cumulative effect of
genetic and/or environmental perturbations on synaptic home-
ostasis during development is exceeded61. Here in this study, we
identified that the second postnatal week is the critical period to
develop alterations in inhibitory circuits and to precipitate ASD
behavioral phenotypes in mature animals. We further demon-
strate that behavioral abnormalities in both haploinsufficiency
and gene duplication models of FOXG1 syndrome are caused by
the simultaneous disruption of FOXG1 levels in excitatory and
inhibitory neuronal circuits. To our surprise, while the E/I bal-
ance in cortical circuitry was only transiently disrupted during the
critical period in all of our socially impaired FoxG1 animal
models (Heterozygous, Low and High), this perturbation was
sufficient to cause behavioral symptoms in adults. We conclude
that inhibitory circuit development during the critical period is a
key aspect of ASD etiology, and that weakening or augmenting
GABAergic tone during this period exacerbates and ameliorates
the respective adult ASD social phenotypes.
It was only recently discovered that FOXG1 duplication and
haploinsufficiency both lead to syndromic forms of
ASD24–28,30–32. Here, we demonstrate that the dose-dependent
aspect of FOXG1 syndrome can be modeled in the mouse by
implementing our novel genetic strategies. To our surprise,
balanced dysregulation of FoxG1 in both excitatory and inhibitory
circuits was necessary to develop ASD-related social behavioral
alterations. This is in contrast to what has been shown in con-
ditional mutation studies of syndromic ASD genes such as Mecp2
and Ube3a8,9. Our current hypothesis is that proper FoxG1 levels
in both excitatory and inhibitory neurons are necessary to
maintain circuit homeostasis. Our cell transplantation study
supports this notion since addition of wild type MGE-derived62
GABAergic precursors into the FoxG1-Heterozygous neuronal
networks ameliorates the social behavioral deficits (Fig. 6).
Importantly, the GABAergic populations affected in our FoxG1
Low and High manipulations include the local interneurons in
the hippocampus, cortex, amygdala and striatum as well as
striatal projection neurons, whose malfunction has been also
implicated in ASD etiology34,63. It will thus be interesting in the
future to investigate the contribution of each forebrain
GABAergic cell type64 to the ASD-like social behavioral pheno-
types in our FoxG1model animals. Considering the central role of
FoxG1 in regulating forebrain development, and its dynamic
activity during discrete phases of circuit maturation20, it is likely
that FoxG1 is an important component of the brain’s homeostasis
machinery. Thus, perturbations in FOXG1 expression result in a
Fig. 4 An early juvenile ASD critical period is revealed by timed FoxG1 dysregulation and imbalanced excitatory-inhibitory circuits. a, b In addition to
FoxG1 Glu+GABA High manipulation at 1 week (Fig. 3a, b), FoxG1 augmentation was carried out at 3 weeks or only during 1–3, 1–2 or 2–3 weeks by
replacing doxycycline diet with a regular one (Fig. 3a scheme). While the sociability of 1–3w and 1–2w High animals is altered to a similar extent as the 1w
High animals, 3w High model is comparable to control animals. n= 24, 23, 34, 19, p= 3.29 × 10−6****,= 4.28 × 10−5****,= 0.130,= 6.87 × 10−5****,=
0.794,= 5.10 × 10−5****,= 0.00512**,= 0.669 (from 3w High to right) Sociability scores of the animal models are cross correlated in a manner similar to
Figs. 1c and 3c. The ASD critical period is identified as being between 1 and 2 weeks (b, left) since FoxG1 augmentation during this time is sufficient for the
animals to develop social behavioral impairments (b). p= 0.0183*, 0.102, 0.00591**, 0.000184***, 0.206 (b, from top to bottom). c–h Miniature EPSCs
and IPSCs were recorded from the layer 2/3 pyramidal neurons of the medial prefrontal cortex (prelimbic and infralimbic, c right) at the holding potentials
of −60mV and 0mV, respectively. c Examples traces of the Wild Type and FoxG1 Heterozygous, Low (neuronal Glu+GABA) and High (1 week Glu+
GABA) ASD model animals (c) at juvenile stages (P12-14). Representative example of a filled layer 2/3 wild type pyramidal cell is shown with a 100 µm
scale bar (right). d, e The E/I ratio is attenuated in all of the socially impaired FoxG1 model animals. n= 23, 22, 15, 15 for WT, Het, Low and High, p=
0.0341*, 0.000111***, 0.821,= 0.00478**, 7.13 × 10−5****, 2.06 × 10−7****,= 0.605, 0.243, 3.70 × 10−5**** (d, vs WT from left to right for E/I, mEPSC
and mIPSC), p= 0.380, 4.22 × 10−7****, 3.61 × 10−8****,= 0.585, 0.0579, 0.000304***,= 0.199, 0.00568**, 0.230 (e, similar to d). f–h Data in adult
(6–8 weeks) mPFC is shown. n= 18, 14, 10, 11 for WT, Het, Low and High, and p= 0.0148*, 0.331, 0.743,= 0.000578***, 0.957, 0.640,= 0.0582, 0.134,
0.574 (g, similar to d) and= 0.283, 0.572, 0.954,= 0.0512, 0.208, 0.830,= 0.217, 0.110, 0.985 (h, similar to d). Note that no obvious changes in the E/I
ratio were found in the adult somatosensory barrel cortices (Supplementary Fig. 6). Data are mean ± SEM, p values are from two-tailed t-test.
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failure of homeostasis that may represent a common etiological
mechanism for ASD. Consistent with this idea, FOXG1 may
participate in the regulation of mitochondrial function65, which
presents another potential link to ASD etiology66,67. In total, we
conclude that FOXG1 likely regulates multiple sets of target genes
in a manner analogous to other ASD-related transcriptional
regulators such as MECP268,69 and CHD870,71.
While FOXG1 haploinsufficiency and duplication have both
been classified as syndromic forms of ASD, there are differences
found in the disease phenotypes24–28,30–32. Consistent with this,
our mouse models for FoxG1 haploinsufficiency (Het and Low)
and augmentation (High) show distinct phenotypic outcomes.
While the sociability scores of the Het, Low and High models are
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in social novelty assays (Figs. 3b and 4a). In addition, the High
model shows a decrease in the E/I amplitude but not the fre-
quency at juvenile stages (Fig. 4d, e) and the values for gamma
EEG are not identical to the haploinsufficiency models (Fig. 3l).
Thus, while FOXG1 augmentation has been proposed to be
etiologically relevant in idiopathic ASD patients23, FOXG1 hap-
loinsufficiency could be a distinct syndrome within the spectrum
of ASD. Similar to FOXG1, copy number variants in MECP2 with
an extra copy (Duplication syndrome) or deletion (Rett) have
both been observed in syndromic ASD patients1,72. While Mecp2
and FoxG1 have been shown to interact directly in neuropro-
tection studies73, the clinical presentations of FOXG1 and MECP2
related syndromic ASDs are distinct74. Consistent with this idea,
in contrast to the Mecp2 mutants, FoxG1 adult mouse models do
not exhibit increases in cortical E/I activity.
It has long been suggested that GABAergic neuron dysfunction
contributes to the pathophysiology of ASD2,3,5,6. Although a
central role for the critical developmental period of inhibitory
circuits in ASD etiology has not been proposed, recently, by using
a juvenile social isolation paradigm, the proper maturation of
Pvalb-positive interneurons in the mPFC has been shown to be
important for animal social behavior75. While this study high-
lights the social experience- (3 to 5 weeks) and interneuron-
dependent (Pvalb subtype) critical period of mPFC for social
behavior, our study defines an innate developmental critical
period for mPFC social circuits and ASD. Interestingly, by ana-
lyzing intrinsic electrophysiological properties76, we found clear
alterations in putative Pvalb subtype (Fast-spiking) interneurons
of the FoxG1 Heterozygous model already at two weeks, in
contrast to pyramidal cells that were found to be abnormal at
later timepoints (Supplementary Fig. 8).
Cortical activity during early postnatal development has been
shown to facilitate cortico-striatal coupling, and decreasing the
cortical hyperactivity observed in the Shank3B mutant ASD
model mouse during this period was able to rescue the striatal
phenotypes63. Moreover, in rodent ASD models, the connectivity
between the mPFC and areas such as the striatum, basolateral
amygdala and ventral tegmental area has been proposed to be
disrupted77. By analyzing Gad2 mutant animals, we provide
direct evidence that a decrease in overall GABAergic synaptic
tone leads to ASD-like social behavioral impairments, to a
comparable extent as observed in the FOXG1 syndrome model.
In addition, our Gad2 mutant studies revealed that a reduction in
GABAergic tone further exacerbates the ASD social phenotypes
of the FoxG1 model. This strongly supports the notion that
transient circuit E/I imbalance during the critical period does not
simply reflect homeostatic compensation per se, but rather is a
causative driver of ASD phenotypes in adult FOXG1 syndrome
model animals. Thus, it will be interesting to investigate the E/I
balance in juvenile animals of other established ASD models12.
Consistent with mPFC circuits playing central roles in regulating
social behavior, social impairments have been rescued in several
contexts by directly manipulating mPFC activity while animals
are executing behavioral tests4,51,52,75. Here in this study, we were
able to developmentally ameliorate the sociability deficits in our
ASD model animals. Thus, our findings on the putative ASD
critical period pinpoints a developmental stage in GABAergic
circuits that offers a possible route for therapeutic intervention.
Methods
FoxG1 perturbation model animals. All animal handling and experiments were
performed in accordance with protocols approved by the respective Institutional
Animal Care and Use Committees of the NYU School of Medicine, Tokyo
Metropolitan Institute of Medical Science and Tokyo Women’s Medical University.
Animal cages are maintained at 22 °C ± 1 °C, 50 ± 15% humidity with a 12 h light/
dark cycle. To generate the FoxG1 Heterozygous model, we combined a FoxG1
LacZ knock-in null allele13 with the wild type FoxG1 allele. FoxG1 Low models
were generated by crossing male Nex-Cre43; Dlx-Cre animals44 with female FoxG1-
C/C; R26-CAG-FRTed stop-EGFP homozygous animals59 (RCE:FRT, Jackson
Laboratories stock #10812). Upon Cre-mediated recombination, the conditional
floxed-FoxG1 allele is converted into a Flpe knock-in allele20, and thus the
recombination efficiency in each animal can be evaluated by EGFP expression from
the Flp-dependent EGFP reporter RCE:FRT. FoxG1 High models were generated by
crossing male Nex-Cre; Dlx-Cre animals to female R26-stop-tTA homozygous78
(Jackson Laboratories stock #008600); TRE-FoxG1 homozygous animals79. In order
to delay FoxG1 augmentation until after postnatal 1 week, a doxycycline-containing
diet (200 PPM, #1810413 Test Diet) was provided to the pregnant females from the
date of the observed plug until postnatal day 7. 3 week High and 1–3 week High
models were generated by replacing the doxycycline diet with a regular one at P21
and during P7 to P21, respectively. Other variations of 1–2 and 2–3 week High
animals were generated in a similar manner. The TRE-FoxG1 allele contains an
IRES-LacZ cassette downstream of the FoxG1 coding sequence and thus, the cor-
responding FoxG1 GOF population can be visualized based on X-gal staining or by
using anti-beta-galactosidase immunohistochemistry. In order to carry out litter-
mate studies for FoxG1;Gad2 compound mutants, double-heterozygous male
FoxG1-LacZ; Gad2 animals were crossed to female Gad2 heterozygotes53,54.
Tissue preparation and immunohistochemistry. Embryos were dissected out,
and transcardiac perfusion was performed with cold 4% formaldehyde/PBS solu-
tion (w/v). Brain dissection was carried out in PBS in a petri dish, and brains were
subsequently placed into 4% formaldehyde/PBS solution on ice. The P7 to P21 as
well as adult brains were also perfused with the same fixative. Brains were postfixed
according to developmental stages (E14.5: 20 min, E16.5: 40 min, E18.5 onwards:
60 min) and, following a brief rinse in PBS, were placed into cold 25% sucrose/PBS
(w/v) solution for cryoprotection until they sunk to the bottom. Subsequently,
brains were mounted in OCT compound (Sakura Finetek) and stored at −80 °C.
Cryosections were prepared at 12 μm thickness and collected on glass slides (Fisher
or Matsunami), and, after over 1 h of drying, the sections were stored at −80 °C.
Immunohistochemistry was performed similarly to previously described20,59,60. All
reactions were carried out in PBS containing 1.5% normal donkey serum (Jackson
Immunoresearch) (v/v) and 0.1% Triton X-100 (v/v) (DST solution), which we
generally keep at 4 °C up to two weeks. By using a liquid blocker pen (#Z377821,
Sigma), two lines are placed in between the section nearest to the frost of the slide
and the frost to restrict the movement of liquid on the slide glass. Sections were
rinsed 3 times in PBS to remove residual OCT, followed by non-specific antibody
blocking, which was carried out in DST solution at room temperature for 30–60
min. Primary antibody incubation was subsequently performed overnight at 4 °C.
Primary antibody was included in the DST solution at the following concentra-
tions: Rabbit anti-GFP (1:2000; Molecular Probes, #A11122), Rat anti-GFP
#GF090R (1:2000; Nacalai Tesque, #04404-84), Rabbit anti-RFP Living Colors
DsRed Polyclonal Antibody (1:2000; Takara Bio Clontech, #632496), Rat anti-RFP
Fig. 5 Decrease in GABAergic tone exacerbates the ASD social phenotypes of the FoxG1 Heterozygous model. Gad2 heterozygous and null littermate
animals in the background of wild type and FoxG1 Heterozygous model were analyzed by three-chamber assay. a Example traces of the animals are shown
for the four genotypes. b In contrast to the Gad2 Het animals, Null animals showed ASD-like social behavioral alterations by not preferring the social side of
the chamber (NS, purple) and staying in the center during the social novelty session (asterisks, purple). c Gad2 Het and Null animals in the FoxG1
Heterozygous background showed ASD like social behavioral impairments, and during social novelty session, strongly preferred to stay in the center
chamber compared to the control animals. n= 22, 28, 21, 25, 29, 20 (b, c, from left to right), p= 3.56 × 10−7****, 0.000234***, 1.62 × 10−5****, 0.0452*,
0.101, 0.00577**,= 0.380, 0.676, 0.000264***, 0.156, 0.562, 0.838 (b, c, left vs right),= 0.825, 0.00781**, 0.0396*, 0.000326***, 0.000521*** (b, c, vs
WT, center). d Social behavior scores of the Gad2 and FoxG1mutant models. While the score of Gad2 nulls is comparable to the FoxG1 Heterozygous model
(purple bars), Gad2 Het or Null mutations exacerbates the impaired sociability score of FoxG1 Heterozygotes (dark bars). p= 0.283, 0.00294**,
0.00738**, 1.25 × 10−7****, 6.49 × 10−6****(vs WT, from top to bottom),= 0.0188*(Gad2WT vs Het in FoxG1 Het background). e Working memory is not
affected by Gad2 mutation(s) in both wild type and FoxG1 Heterozygotes. n= 44, 56, 40, 48, 58, 40 (from left to right), p= 0.0121*(WT vs FoxG1 Het),=
0.352, 0.320, 0.339, 0.460(NS, from left to right). Data are mean ± SEM, p values are from two-tailed t-test.
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#5F8 (1: 2000; Allele Biotechnology, #ACT-CM-MRRFP10). Secondary antibodies
conjugated with Alexa Fluor dyes 488 or 594 for anti-Rabbit Alexa 488 (Invitrogen,
#A-21206), anti-Rat Alexa 488 (Invitrogen, #A-21208), anti-Rabbit Alexa 594
(Invitrogen, #A-21207), anti-Rat Alexa 594 (Invitrogen, #A-21209) raised in
donkey and cross-adsorbed against other species were used in 1:2000 dilution for
fluorescent immunohistochemistry. In order to visualize the cell nuclei and laminar
structure of the developing neocortex, DAPI (Sigma) (1 ng/µl in PBS and filtrated)
was added on slides for 20–30 min following the immunohistochemistry staining
procedure described above. Slides were rinsed a couple of times in PBS and then
coverslipped using Fluoromount G (Southern Biotech). Fluorescent images were
captured with a Zeiss AxioScope.A1 (Carl Zeiss) by using a cooled-CCD camera
(Princeton Scientific Instruments, NJ) with Metamorph software (Universal Ima-
ging, Downingtown, Pennsylvania) or by using a QSI RS 6.1s cooled-CCD camera
(2758×2208 pixels, QSI) with micro-manager (open source software). Fluorescent
in situ hybridization was carried out by using a Gad1 anti-sense probe and by
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Fisher Scientific) following a similar protocol similarly to previously described80. In
order to facilitate the visualization of gene expression, acquired images were
inverted in Photoshop (Adobe) and subsequently combined to generate the figures.
For example, tdTomato fluorescent images were placed into both the green and
blue channels of the RGB format file and then all color channels were simulta-
neously inverted to generate a figure with red signals in the white background. For
a multicolor presentation, layers including different color signals were assembled
by using the function of multiply layers.
Western blotting of mPFC tissue. Brain slices were prepared in a similar manner
to the in vitro electrophysiological recordings (300 µm thickness) or by generating
a coronal slice with a cutting blade (typically ~400 µm). In the petri dish, mPFC
was bilaterally dissected out from the slice with forceps, placed into a 1.5 ml tube
and immediately stored in −80 °C freezer. After obtaining tissue samples from the
Het, Low and High models at various postnatal stages, and in addition, E16
embryonic cortical Het and Null tissue as positive controls, protein lysate was
prepared. For each sample, 200 µl of SDS lysis buffer (1% SDS, 10 mM Tris pH7.5,
5 mM EDTA, 1tablet/10 ml Protease inhibitor cocktail (Roche: 11-836-153-001),
1tablet/10 ml PhosSTOP (Roche: 04-906-837-001)) was added and homogenized
with pipetting. After vortex mixing the samples, tubes were centrifuged for 15 min
with 20,630 × g/15,000 rpm and subsequently, the supernatant protein concentra-
tion was analyzed by using the BCA Protein Assay Kit (Thermo Scientific #23227).
Total 4 µg of protein lysate from each sample was applied to the well of Mini-
Protean TGX 4–15% Gel (BIORAD #456-1086) for western-blotting analysis. We
initially compared three FoxG1 antibodies of Rabbit anti-FoxG1 (Neuracell, #NC-
FAB), Rabbit anti-FoxG1 (Abcam, #ab18259) and Rabbit anti-FoxG1 monoclonal #
EPR18987 (Abcam, #ab196868) in 1:10,000 concentration for E16 wild type and
FoxG1 null cortical tissues. We decided to use the rabbit monoclonal # EPR18987
(1:10,000 concentration) because we detected almost no background bands in Null
tissues, as well as the positive band was clear (Supplementary Fig. 5a). Gel blotting
was performed with a regular procedure by using a 0.45 µm Nitrocellulose mem-
brane (Biorad #1620116) or Immobilon PVDF membrane (Millipore#IPVH07850)
and after using 5% ECL blocking reagent (GE Healthcare # RPN2125V) in TBST,
antibody reactions were carried out for rabbit mono FoxG1 or mouse monoclonal
βactin antibody #AC-15 (1:50,000; SIGMA Aldrich #A5441-2ml) or mouse
monoclonal Tuj1 antibody #TU-20 (1:5000; Millipore # MAB1637). After 1 h of
secondary reaction with 1:5000 HRP-conjugated anti Rabbit or Mouse antibodies
(Jackson ImmunoResearch #115-035-003 or 111-035-003) and subsequent washing
of the membrane, signals were recorded by Clarity Western ECL Substrate (Biorad
#1705061) and Image Quant LAS 4000 (GE Healthcare). When required, antibody
stripping from the membrane was performed by 30 min incubation at 55 °C with a
stripping solution containing 2% SDS, 100 mM mercaptoethanol, and 62.5 mM
Tris-HCl (pH 6.8). Obtained signals were analyzed by using the Image J software.
GABAergic cell precursor transplantation. In order to prepare donor EGFP-
labeled GABAergic cell precursors, we crossed males double positive for Dlx5a-
Cre44 (Jackson Laboratories stock #008199) and R26-CAG-loxPstop-EGFP reporter
homozygous59,81 (RCE:loxP; Jackson Laboratories stock #10701) to wild type
female animals. At E13.5, embryos were dissected out and the ones harboring green
brains were confirmed by using a fluorescent dissection microscope (Olympus, SZX
12). From each embryo, two MGEs (medial ganglionic eminence)62 from both
hemispheres were collected. We typically used total 8 embryos for donor but in
case we do not have 8 EGFP-positives, we combined EGFP-negative embryos as
well. For cell dissociation, brains were dissected out in HBSS solution (Gibco
#14175-095) one by one, each pair of MGEs were dissected out and stored in a 1.5
ml flat-bottom micro tube (Watson #131-815CS) with 500 µl of HBSS solution and
kept on ice until the dissection was complete for maximum 8 embryos. Later,
tissues were rinsed twice with HBSS and 100 μl of DNAse I (20,000 ku/ml in HBSS,
Worthington) and 400 μl of Papain (20 u/ml in HBSS, Worthington #LK003176)
solution were immediately added. By gentle pipetting (typically around 5 times)
with a 200 μl filter tip pipette, tissues were broken up into small pieces. After a 20
min of incubation at 37 °C with shaking, 750 μl of 1% (v/v) heat-inactivated horse
serum (Gibco #26050-070) in ice-cold HBSS and 75 μl of DNAse I (2000u/ml in
HBSS) were added. After gently inverting the tube a couple of times, the tube was
centrifuged for 5 min at 200 g/1480 rpm at 4 °C, the supernatant was discarded,
500 μl of ice-cold DMEM/GlutaMax (containing 5 μl of DNAse I) was added, and
the cell pellet was resuspended by gentle pipetting using a 200 μl filter tip pipette.
Cells are then collected into a 1.5 ml flat-bottom tube through 40 µm mini cell-
strainer II (Hi-tech-inc# HT-AMS-04002, blue). The cell-strainer is rinsed with
another 500 μl of ice-cold DMEM/GlutaMax containing 5 μl of DNAse I to make
total 1 ml cell solution. Cell numbers were counted on OneCell counter (Fine Plus
International Ltd). MGEs from 8 embryos typically ended up with 6000–8000 cells/
µl in 1 ml cell solution. 1 ml of cell solution was centrifuged for 5 min at 4 °C, 200
g/1480 rpm and supernatant was removed to leave 15-20 µl with the cell pellet.
After an addition of 0.5 µl of DNAse I (2000 u/ml in HBSS), the tube was vortex
mixed and kept on ice for cell transplantation surgery.
In the afternoon, P7 pup was placed in a bag and buried under crushed ice for
15 min to have sufficient anesthetization. For 3 week old experiments, animals were
first anesthetized with 2% isoflurane and then intraperitoneal injection of ketamine
(100 mg/kg) and xylazine (16 mg/kg) mixture was carried out. 3 µl of cell solution
was placed on a parafilm (typically for 3–4 pups) and was adsorbed into a 36 g
beveled NanoFil injection needle (World Precision Instruments, #NF35BV-2) at
300 nl/min ratio. Surgical tape-protected ear-bars are placed bilaterally to fix the
pup head. The skin of the head above the olfactory bulbs was cut in the center for
about 3–5 mm to visualize the skull. 1.7 mm posterior and 0.2 mm lateral from the
blood vessel crossing, which is located above the border of nasal and frontal skull
was aimed. Prior to needle injection, cells are released from the needle to confirm
the clogging. The needle tip is placed 1.5 mm deep from the surface, and 200 nl of
cells are injected at 200 nl/min speed. Upon completing the cell injection, the
needle was kept still for another minute and then removed from the skull slowly.
Upon completing the cell injection into the right hemisphere, pup status was
confirmed, and if necessary, a small ice pack was placed below the belly of the pup
before proceeding to the left hemisphere injection. When done with the injections
into both hemispheres, the head was thoroughly wiped, the skins were put together
with instant glue and the pup was placed on the warm pad for a while before
sending back to the littermate cohort. The entire surgery takes approximately 25
min for one pup.
Behavioral assays. The date of the observed plug was designated as E0 and pups
were usually delivered on E19. At postnatal day 21, the whole litter was weaned and
placed into a larger cage (W270 × L440 × H187 mm, KN-601, Natsume Seisakusyo)
from the original cage (W220 × L320 × H135 mm). Genotyping of the animals by
tail PCR was carried out by postnatal 2 weeks. Upon completing battery of
behavioral analyses, we again carried out tail PCR to assure the genotypes of the
animals. Open field and elevated plus maze behavioral assays were carried out on
cohorts of animals at 5 weeks of age. The following week, the three-chamber assay
Fig. 6 Normalization of the mPFC E/I balance by incrementing GABAergic tone during the critical period ameliorates social phenotypes in the FoxG1
ASD model. a Donor GABAergic cell precursors were dissected out from the MGE (medial ganglionic eminence, arrowhead) of E13.5 embryos and
dissociated. Subsequently, donor cells were bilaterally transplanted into the mPFC (medial prefrontal cortex) of 1 week old FoxG1 Heterozygous or Wild
Type animals. The E/I balance of layer 2/3 pyramidal cells was analyzed at 2 weeks (DIC image) and the social behavioral assay was carried out at
6 weeks. b A representative example of cell-transplanted mPFC slices after the E/I analysis at 2 weeks. A biocytin-filled pyramidal cell and EGFP-labeled
GABAergic cell transplants are shown. Control wild type and the Heterozygous animals maintained a similar density of transplanted cells within the adult
mPFC (Supplementary Fig. 7b–d). c–f E/I balance data for frequency and peak amplitude values at 2 weeks (c, d, n= 16) and in adults (e, f, n= 22). Cell-
transplanted Heterozygotes showed comparable E/I ratios to the control Wild Type animals (NS in orange) for both frequency (p= 0.424) and amplitude
(p= 0.148) at 2 weeks and in adulthood (p= 0.379 and 0.828). p= 8.04 × 10−8****, 7.47 × 10−8**** (c, mEPSC and mIPSC),= 0.0438*, 0.00294**(d),
= 0.291, 0.115 (e), = 8.69 × 10−8****, 2.95 × 10−7**** (f). g–j Upon receiving GABAergic cell precursors at 1 week (g, h, left scheme), social behaviors of
Wild Type (n= 34) and Hets (n= 29) were analyzed by three-chamber assay (g, h). In addition, in order to test the importance of rebalancing E/I ratio of
the Hets during the critical period (1–2 weeks), cell transplantation was carried out at postnatal 3 weeks (i, n= 21). Time spent in the social side of the
chamber during sociability sessions (NS in orange, p= 0.202) and center chamber during social novelty sessions (NS in orange, p= 0.222) were
comparable between the 1 week-transplanted Wild Type and Heterozygotes (j). p= 4.48 × 10−7****, 1.32 × 10−6****, 0.0877, 0.00126**, 0.00264**,
0.275 (j, left vs right, from left to right). k The impaired sociability score in the Heterozygotes is ameliorated (p= 0.122) and exacerbated in the GABAergic
cell precursor transplantation and Gad2 mutation models, respectively. l In contrast to social behavior (j, k), working memory deficits of the Heterozygotes
were not ameliorated upon GABAergic cell transplantation into the mPFC (n= 54, p= 0.698). Data are mean ± SEM, p values are from two-tailed t-test.
Scale bars: 1 mm (a, left), 20 µm (a, right), 100 µm (b).
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and 8-arm radial maze working memory task were performed. Mice of both
genders were included in our analysis. All of the assays were carried out in a sound-
proof room (S-1220 soft DX, STAR LITE) and mouse behavior in each specific
arena was recorded by a CCD camera (Chameleon3 1.3 MP Mono USB3 Vision,
CM3-U3-13S2M-CS, FLIR) at 15 frames/sec and saved as M-JPEG file with 75%
compression by using FlyCapture2 camera software 2.9.3.11 (Photonics). Prior to
initiating the recording, the information of the test animal, such as date of filming,
animal number, and presence or absence of a social animal, were written on a small
white board (22 × 33 cm) and placed on the behavior testing set. After video
recording had been initiated, the white board was removed and the test animal was
placed in the arena or the starting dome was removed to release the test animal.
Once testing had begun, the experimenter would quickly leave the sound-proof
chamber and quietly close the door in order to provide a non-disturbing envir-
onment to the test animal during the assay. The experimenter was always blind to
the genotype of the test animals. Video files were later analyzed by using the ANY-
maze video tracking software 5.1 (Stoelting, USA), with the video analysis typically
initiated after the door had been closed. All behavioral analysis data are shown as
mean ± SEM and p values are from two-tailed t-test.
Open field assay. The open field apparatus consists of a gray acrylic-modified
polyvinyl-chloride floor with a 50 × 50 cm square field and gray vinyl chloride 40
cm height walls (OF-36MSQ, Muromachi). Animals were placed in the center of
the arena and the recording was performed for 10 min and 30 s. Data were ana-
lyzed over the 10 min session for the distance traveled and time spent in the center
(30 × 30 cm square center) and margin of the chamber.
Elevated plus maze. The apparatus material is similar to that of the open field
chamber, and the length of each of the open and closed arms is 30 cm, with a
corridor width of 6 cm (EPM-04M, Muromachi). The walls of the closed arm are
15 cm in height. At the beginning of the assay, animals are placed on one end of the
open arms and allowed to explore freely during the 10 min and 30 s recording
session. Distance and time each animal spent on the open and closed arms were
analyzed for the first and second 5 min of the assay.
Three-chamber social interaction assay. The apparatus consists of a gray acrylic-
modified polyvinyl-chloride floor and three chambers (each 20 × 40 cm) connected
by 5 cm width × 7 cm height windows in transparent acryl 22 cm height walls (SC-
03M, Muromachi). Wired cages are 18.5 cm height with 9 cm diameter circle
bottom and top, both of which are connected by 3 mm diameter wires (total 16)
placed in a circle with 7 mm distance between wires. Out of the four wired cages,
two were used to place the stranger mouse but the other two did not receive
animals and were used for the Habituation (1st 10 min) and non-social side of the
Sociability session (2nd 10 min). The chambers and wired cages were cleaned and
dried with paper towels between each test animal trial. The test mouse is first
placed in a start dome (20 cm diameter circle tube, transparent acryl) in the middle
chamber. Upon removal of the start dome, the experimenter quickly left the sound-
proof room and closed the door quietly. In the first session (Habituation), the
animal was allowed to freely move inside the three-chambers with two empty wired
cages placed in the centers of the lateral chambers. After 10 min and 30 s video
recording was obtained, the test animal was allowed to move into the middle
chamber and was trapped in the start dome. At the beginning of second session
(Sociability), one of the empty wired cage was replaced with another wired cage
holding an age- and gender-matched stranger mouse. After 10 min and 30 s of
video recording, the test animal was again trapped inside the starting dome in the
middle chamber. Then, the remaining empty wired cage was replaced with a
stranger animal-containing wired cage for the final session (Social Novelty). After
the video recording was complete, the test animal was returned to its littermate
home cage. For each 10 minutes of assay, time spent in each of the three chambers
was measured and analyzed.
8-arm radial maze working memory task. The maze is made from a material
which is similar to the open field, and each arm is 35 cm length with 6 cm wall
heights (RM-08M, Muromachi). The center part of the arms (10 cm) have higher
walls (12 cm) and the distance between the opposing two arms spanning the center
area is 20 cm. At the end of each arm, there is a circle hole (2 cm diameter, 1 cm
depth) with a small dip (0.5 cm diameter, reverse cone shape) in the center. Prior to
initiating the task, 50 µl of water droplets are carefully placed into all of the eight
dips by using a pipette. The test animal is placed in a start dome (20 cm diameter
circle tube, transparent acryl), which is placed in the center of the arena. The assay
starts by removing the start dome and the experimenter leaving the sound-proof
chamber and closing the door. In terms of the test model animals, water bottles
were removed from the cage in the morning of one day prior to the first experi-
ment. On the first day, assays are carried out for two rounds (R1 and R2) typically
in the morning and the afternoon. On the second day, another two rounds of
experiments (R3 and R4) are carried out. In all of the tests, video recording was
carried out for 5 min and 30 s. With the ANY-maze software, the analysis of video
file is initiated when the test animal reaches the first end of the arm by its body
trace dot crossing a line located 10 cm away from the end of arm. When the test
animal has entered the eighth end of the arm, the trial is terminated; otherwise it
ends after 5 min. The duration to complete the task, total numbers of the end of the
arms visited and the mean speed was measured for each animal in the R3 and R4
trials for analysis. Note that when a test animal does not complete the task within 5
min, the total numbers of visits, as well as duration, are both underestimated.
Electroencephalogram recording
EEG and EMG recordings of freely-moving animals. Stereotaxic surgery was per-
formed under anesthesia with a ketamine-xylazine mixture (100 and 10 mg/kg,
respectively, i.p.). Electrodes for EEG were implanted on the skull over the left and
right prefrontal cortex (+3.0 mm anteroposterior, +1.5 mm mediolateral from
bregma; +1.1 mm anteroposterior, +1.5 mm mediolateral from bregma) according
to the mouse brain atlas82. Electrodes for EMG were inserted into the neck muscles.
Continuous EEG and EMG recordings were performed through a slip ring (SPM-
12, Hikari Denshi Kogyo) designed so that the movement of mouse was unrest-
ricted. EEG and EMG signals were amplified (BA1008, Miyuki Giken), low-pass-
filtered at 100 Hz, digitized at a sampling rate of 400 Hz, and recorded using
LabChart v7.3.8 software (AD instruments). For the vigilance state determination,
EEG/EMG recordings were scored by visual inspection as wakefulness, NREM
sleep, or REM sleep in 8-sec epochs following the criteria83. The same individual,
blinded to experimental conditions, scored all EEG/EMG recordings. Spectral
analysis of the EEG was performed by fast Fourier transform (SleepSign software
version 3.0, Kissei Comtec). The EEG signal were filtered by 0.5 Hz high-pass filter
and 50 Hz notch filter. This analysis yielded a power spectral profile over a 0.5–80
Hz window with a 0.2 Hz resolution divided into delta (0.75–4 Hz), theta (4–12
Hz), alpha/beta (12-30 Hz), low-gamma (30–45 Hz), and high-gamma (55–80 Hz)
waves. Whereas the recordings were obtained for more than 24 hr, the EEG data in
wakefulness state early in the dark period (from 22:00 to 0:00) was used for the
spectral analyses. The absolute power was divided by the total power (0.5–80 Hz) in
24 hr. The mean normalized power in each frequency band was then calculated for
each subject.
Sensory-evoked EEG recordings in awake head-fixed animals. In order to prepare
for EEG recording, a custom-made head plate was implanted onto the skull of 7–8
week-old adult FoxG1 model animals using acrylic dental resin (Super-Bond, Sun
Medical, Shiga, Japan). Prior to this surgery, mice were anesthetized with an
intraperitoneal injection of ketamine (100 mg/kg) and xylazine (16 mg/kg) mixture
and held in a stereotaxic apparatus. The head plate-implanted animals were placed
back in the home cage and allowed to recover from the surgery for 2 or 3 days. For
EEG recordings, the animals were first anesthetized with 2% isoflurane to insert
screws. A reference screw was inserted into the skull on top of the right cerebellum
and recordings were from a screw on top of the right cortex (1 mm anterior and
0.5 mm lateral to bregma). EEG recordings were obtained from head-fixed mice
during the awake state. The EEG signal was amplified and digitized at 4 kH by
Plexon OmniPlexD system Ver. 1.12.0.0 (Plexon Inc., Dallas, TX, USA). EEG data
were analyzed using a custom-written MATLAB program (MathWorks, Natick,
MA, USA). Whiskers were stimulated by using a piezoelectric device controlled by
a custom-written MATLAB program. The codes are available from the corre-
sponding author upon reasonable request. All whiskers were deflected toward
forward and backward directions for 30 ms with a 170 ms steady state interval after
each deflection. This stimulation protocol was carried out four times in one session,
which was repeated 20 times at 3.6 s intervals. Recordings with and without sti-
mulation were carried out for 1.6 s after and before the first whisker deflection,
respectively.
In vitro electrophysiological recordings. Juvenile (P12-14) and adult (6–8 weeks)
male or female mice were deeply anesthetized with pentobarbital (100 mg/kg,
intraperitoneal) and the brains were quickly removed and submerged in an ice-cold
cutting solution (234 mM sucrose, 2.5 mM KCl, 10 mM MgCl2, 0.5 mM CaCl2, 25
mM NaHCO3, 1.25 mM NaH2PO4, 0.5 mM myo-inositol, and 11 mM glucose).
Coronal brain slices were cut using a vibratome (300 µm, VT-1200S, Leica) and
immersed in a physiological solution (125 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 2
mM CaCl2, 26 mM NaHCO3, 1.25 mM NaH2PO4, 20 mM glucose, 5 mM Na-
ascorbate, 3 mM Na-pyruvate, and 2 mM thiourea) that was continuously bubbled
with a mixture of 95% O2 and 5% CO2. Na-ascorbate, Na-pyruvate, and thiourea
were omitted during recordings. Whole-cell patch clamping was performed at
31–32 °C. Voltage-clamp recordings were made from visually identified layer 2/3
pyramidal neurons in the prelimbic cortex (PFC, prefrontal cortex) or barrel fields
of the primary somatosensory cortex (S1).
The pipette solution for current-clamp recordings consisted of 130 mM
potassium gluconate, 0.2 mM EGTA, 2 mM MgCl2, 2 mM Na2ATP, 0.3 mM
NaGTP, and 10 mM HEPES. The pipette solution for voltage-clamp recording
consisted of 108 mM cesium gluconate, 0.4 mM EGTA, 2.8 mM NaCl, 5 mM TEA-
Cl, 4 mM MgATP, 0.3 mM NaGTP, 10 mM Na2-phosphocreatine and 20 mM
HEPES. In some recordings, 0.5% biocytin was included in the pipette solution to
visualize neuron morphology. The pH of the solution was adjusted to 7.2 and the
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osmolarity was 290 mOsm. The membrane potentials were not corrected for liquid
junction potentials. The series resistance of the recording cells was <25MΩ. For
current-clamp recordings, the resting membrane potentials and firing responses to
depolarizing current pulses (1-s duration, 0–600 pA with 50 pA increments from
the resting membrane potential) were recorded within 5 min from whole-cell
break-in. The input resistance and time constant were determined from the
transient voltage response to a hyperpolarizing current injection (−50 pA). The
voltage sag amplitude was determined by subtracting the steady state amplitude
from the maximum amplitude in response to a hyperpolarizing current pulse
(−200 pA, 1-s duration). For voltage-clamp recordings, miniature excitatory
postsynaptic currents (mEPSCs) and miniature inhibitory postsynaptic currents
(mIPSCs) were recorded as inward currents at −60 mV and outward currents at 0
mV, respectively, from the same neuron in the presence of physiological solution
containing 0.5 µM tetrodotoxin (Alomone Labs, Jerusalem, Israel). After
recordings, slices containing biocytin-loaded cells were fixed overnight at 4 °C in a
fixative (4% paraformaldehyde and 0.2% picric acid in 0.1 M PB) and incubated
with Alexa Fluor 488-conjugated streptavidin (1:500, Thermo Fisher Scientific,
Waltham, MA, USA).
Recordings were amplified with a Multiclamp 700A amplifier (Molecular
Devices, LLC, Sunnyvale, CA, USA), digitized at 10 kHz using a Digidata 1322A
apparatus (Molecular Devices, LLC), and collected with pClamp 8.2 software
(Molecular Devices, LLC). mEPSC/mIPSC events were detected with a scaled-
template algorithm and analyzed using IGOR Pro 6.36 software (WaveMetrics,
Inc., Lake Oswego, OR, USA) and Clampfit 8.2 software (Molecular Devices, LLC).
The amplitude and the frequency of mEPSC/mIPSC events were determined for
each neuron over a 5-min period of recording. Statistical analyses were performed
as follows using Graphpad Prism 7.05 software (GraphPad Software, San Diego,
CA, USA): two-way ANOVA and post-hoc Tukey’s test were used for comparisons
of current-frequency relationships; Welch’s t-test was used for two group
comparisons; and the chi-square test was used for comparison of firing type
composition.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data supporting the findings of this study are provided within the paper and its
Supplementary information. A Source data file is provided with this paper. We confirm
that all unique materials used here are readily available from the authors (FoxG1-LacZ,
floxed-FoxG1, TRE-FoxG1, Nex-Cre, Gad2 null) or from Jackson labs (Dlx5a-Cre, RCE:
FRT, RCE:loxP, R26-stop-tTA, Ai9). Further information on research design is available
in the Nature Research Reporting Summary linked to this article. Any data are available
from the authors upon request.
Code availability
A custom code was used in the EEG analysis of head-fixed animals (Supplementary
Fig. 4). All scripts used to analyze or display the data are available upon request.
Received: 13 September 2020; Accepted: 27 May 2021;
References
1. Sztainberg, Y. & Zoghbi, H. Y. Lessons learned from studying syndromic
autism spectrum disorders. Nat. Neurosci. 19, 1408–1417 (2016).
2. Rubenstein, J. L. & Merzenich, M. M. Model of autism: increased ratio of
excitation/inhibition in key neural systems. Genes Brain Behav. 2, 255–267
(2003).
3. Nelson, S. B. & Valakh, V. Excitatory/inhibitory balance and circuit
homeostasis in autism spectrum disorders. Neuron 87, 684–698 (2015).
4. Yizhar, O. et al. Neocortical excitation/inhibition balance in information
processing and social dysfunction. Nature 477, 171–178 (2011).
5. Marin, O. Interneuron dysfunction in psychiatric disorders. Nat. Rev.
Neurosci. 13, 107–120 (2012).
6. Lewis, D. A., Hashimoto, T. & Volk, D. W. Cortical inhibitory neurons and
schizophrenia. Nat. Rev. Neurosci. 6, 312–324 (2005).
7. Hashemi, E., Ariza, J., Rogers, H., Noctor, S. C. & Martinez-Cerdeno, V. The
number of parvalbumin-expressing interneurons is decreased in the prefrontal
cortex in autism. Cereb. Cortex 1, 1931–1943 (2017).
8. Chao, H. T. et al. Dysfunction in GABA signalling mediates autism-like
stereotypies and Rett syndrome phenotypes. Nature 468, 263–269 (2010).
9. Judson, M. C. et al. GABAergic neuron-specific loss of Ube3a causes angelman
syndrome-Like EEG abnormalities and enhances seizure susceptibility.
Neuron 90, 56–69 (2016).
10. Hensch, T. K. Critical period plasticity in local cortical circuits. Nat. Rev.
Neurosci. 6, 877–888 (2005).
11. Southwell, D. G., Froemke, R. C., Alvarez-Buylla, A., Stryker, M. P. & Gandhi,
S. P. Cortical plasticity induced by inhibitory neuron transplantation. Science
327, 1145–1148 (2010).
12. Antoine, M. W., Langberg, T., Schnepel, P. & Feldman, D. E. Increased
excitation-inhibition ratio stabilizes synapse and circuit excitability in four
autism mouse models. Neuron 101, 648–661 (2019). e644.
13. Xuan, S. et al. Winged helix transcription factor BF-1 is essential for the
development of the cerebral hemispheres. Neuron 14, 1141–1152 (1995).
14. Hanashima, C., Li, S. C., Shen, L., Lai, E. & Fishell, G. Foxg1 suppresses early
cortical cell fate. Science 303, 56–59 (2004).
15. Muzio, L. & Mallamaci, A. Foxg1 confines Cajal-Retzius neuronogenesis and
hippocampal morphogenesis to the dorsomedial pallium. J. Neurosci. 25,
4435–4441 (2005).
16. Shen, Q. et al. The timing of cortical neurogenesis is encoded within lineages
of individual progenitor cells. Nat. Neurosci. 9, 743–751 (2006).
17. Godbole, G. et al. Hierarchical genetic interactions between FOXG1 and
LHX2 regulate the formation of the cortical hem in the developing
telencephalon. Development 145, dev154583 (2018).
18. Martynoga, B., Morrison, H., Price, D. J. & Mason, J. O. Foxg1 is required for
specification of ventral telencephalon and region-specific regulation of dorsal
telencephalic precursor proliferation and apoptosis. Dev. Biol. 283, 113–127
(2005).
19. Manuel, M. et al. The transcription factor Foxg1 regulates the competence of
telencephalic cells to adopt subpallial fates in mice. Development 137, 487–497
(2010).
20. Miyoshi, G. & Fishell, G. Dynamic FoxG1 expression coordinates the
integration of multipolar pyramidal neuron precursors into the cortical plate.
Neuron 74, 1045–1058 (2012).
21. Tian, C. et al. Foxg1 has an essential role in postnatal development of the
dentate gyrus. J. Neurosci. 32, 2931–2949 (2012).
22. Won, H. et al. Chromosome conformation elucidates regulatory relationships
in developing human brain. Nature 538, 523–527 (2016).
23. Mariani, J. et al. FOXG1-Dependent dysregulation of GABA/glutamate
neuron differentiation in autism spectrum disorders. Cell 162, 375–390
(2015).
24. Brunetti-Pierri, N. et al. Duplications of FOXG1 in 14q12 are associated with
developmental epilepsy, mental retardation, and severe speech impairment.
Eur. J. Hum. Genet. 19, 102–107 (2010).
25. Yeung, A. et al. 4.45 Mb microduplication in chromosome band 14q12
including FOXG1 in a girl with refractory epilepsy and intellectual
impairment. Eur. J. Med. Genet. 52, 440–442 (2009).
26. Ariani, F. et al. FOXG1 is responsible for the congenital variant of Rett
syndrome. Am. J. Hum. Genet. 83, 89–93 (2008).
27. Bahi-Buisson, N. et al. Revisiting the phenotype associated with FOXG1
mutations: two novel cases of congenital Rett variant. Neurogenetics 11,
241–249 (2010).
28. Kortum, F. et al. The core FOXG1 syndrome phenotype consists of postnatal
microcephaly, severe mental retardation, absent language, dyskinesia, and
corpus callosum hypogenesis. J. Med. Genet 48, 396–406 (2011).
29. Takahashi, S. et al. FOXG1 mutations in Japanese patients with the congenital
variant of Rett syndrome. Clin. Genet. 82, 569–573 (2012).
30. Florian, C., Bahi-Buisson, N. & Bienvenu, T. FOXG1-Related Disorders: From
Clinical Description to Molecular Genetics. Mol. Syndromol. 2, 153–163
(2012).
31. Seltzer, L. E. et al. Epilepsy and outcome in FOXG1-related disorders.
Epilepsia 55, 1292–1300 (2014).
32. Wong, L. C. et al. FOXG1-related syndrome: from clinical to molecular
genetics and pathogenic mechanisms. Int. J. Mol. Sci. 20, 4176 (2019).
33. Silverman, J. L., Yang, M., Lord, C. & Crawley, J. N. Behavioural phenotyping
assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490–502 (2010).
34. Peca, J. et al. Shank3 mutant mice display autistic-like behaviours and striatal
dysfunction. Nature 472, 437–442 (2011).
35. Orefice, L. L. et al. Peripheral mechanosensory neuron dysfunction underlies
tactile and behavioral deficits in mouse models of ASDs. Cell 166, 299–313
(2016).
36. Han, S. et al. Autistic-like behaviour in Scn1a+/- mice and rescue by
enhanced GABA-mediated neurotransmission. Nature 489, 385–390 (2012).
37. Schmeisser, M. J. et al. Autistic-like behaviours and hyperactivity in mice
lacking ProSAP1/Shank2. Nature 486, 256–260 (2012).
38. Shen, L., Nam, H. S., Song, P., Moore, H. & Anderson, S. A. FoxG1
haploinsufficiency results in impaired neurogenesis in the postnatal
hippocampus and contextual memory deficits. Hippocampus 16, 875–890
(2006).
39. Eagleson, K. L. et al. Disruption of Foxg1 expression by knock-in of cre
recombinase: effects on the development of the mouse telencephalon.
Neuroscience 148, 385–399 (2007).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23987-z ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:3773 | https://doi.org/10.1038/s41467-021-23987-z | www.nature.com/naturecommunications 15
40. Cargnin, F. et al. FOXG1 Orchestrates neocortical organization and cortico-
cortical connections. Neuron 100, 1083–1096.e5. (2018).
41. Dastidar, S. G., Landrieu, P. M. & D’Mello, S. R. FoxG1 promotes the survival
of postmitotic neurons. J. Neurosci. 31, 402–413 (2011).
42. Siegenthaler, J. A., Tremper-Wells, B. A. & Miller, M. W. Foxg1
haploinsufficiency reduces the population of cortical intermediate progenitor
cells: effect of increased p21 expression. Cereb. Cortex 18, 1865–1875 (2008).
43. Goebbels, S. et al. Genetic targeting of principal neurons in neocortex and
hippocampus of NEX-Cre mice. Genesis 44, 611–621 (2006).
44. Monory, K. et al. The endocannabinoid system controls key epileptogenic
circuits in the hippocampus. Neuron 51, 455–466 (2006).
45. Verginelli, F. et al. Transcription factors FOXG1 and Groucho/TLE promote
glioblastoma growth. Nat. Commun. 4, 2956 (2013).
46. Weise, S. C. et al. TGFbeta-signaling and FOXG1-expression are a hallmark of
astrocyte lineage diversity in the murine ventral and dorsal forebrain. Front.
Cell. Neurosci. 12, 448 (2018).
47. Falcone, C. et al. Foxg1 antagonizes neocortical stem cell progression to
astrogenesis. Cereb. Cortex 29, 4903–4918 (2019).
48. Inamura, N. et al. Intrinsic and extrinsic mechanisms control the termination
of cortical interneuron migration. J. Neurosci. 32, 6032–6042 (2012).
49. Orekhova, E. V. et al. Excess of high frequency electroencephalogram
oscillations in boys with autism. Biol. psychiatry 62, 1022–1029 (2007).
50. Rojas, D. C., Maharajh, K., Teale, P. & Rogers, S. J. Reduced neural
synchronization of gamma-band MEG oscillations in first-degree relatives of
children with autism. BMC Psychiatry 8, 66 (2008).
51. Cao, W. et al. Gamma oscillation dysfunction in mPFC leads to social deficits
in neuroligin 3 R451C knockin mice. Neuron 98, 670 (2018).
52. Selimbeyoglu, A. et al. Modulation of prefrontal cortex excitation/inhibition
balance rescues social behavior in CNTNAP2-deficient mice. Sci. Transl. Med.
9, eaah6733 (2017).
53. Yamamoto, T. et al. Development of autoimmune diabetes in glutamic acid
decarboxylase 65 (GAD65) knockout NOD mice. Diabetologia 47, 221–224
(2004).
54. Yanagawa, Y. et al. Enrichment and efficient screening of ES cells containing a
targeted mutation: the use of DT-A gene with the polyadenylation signal as a
negative selection maker. Transgenic Res. 8, 215–221 (1999).
55. Fagiolini, M. & Hensch, T. K. Inhibitory threshold for critical-period
activation in primary visual cortex. Nature 404, 183–186 (2000).
56. Southwell, D. G. et al. Interneurons from embryonic development to cell-
based therapy. Science 344, 1240622 (2014).
57. Martinez-Cerdeno, V. et al. Embryonic MGE precursor cells grafted into adult
rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned
rats. Cell Stem Cell 6, 238–250 (2010).
58. Southwell, D. G. et al. Interneuron transplantation rescues social behavior
deficits without restoring wild-type physiology in a mouse model of
autism with excessive synaptic inhibition. J. Neurosci. 40, 2215–2227
(2020).
59. Miyoshi, G. et al. Genetic fate mapping reveals that the caudal ganglionic
eminence produces a large and diverse population of superficial cortical
interneurons. J. Neurosci. 30, 1582–1594 (2010).
60. Miyoshi, G. et al. Prox1 Regulates the subtype-specific development of caudal
ganglionic eminence-derived GABAergic cortical interneurons. J. Neurosci. 35,
12869–12889 (2015).
61. Bourgeron, T. From the genetic architecture to synaptic plasticity in autism
spectrum disorder. Nat. Rev. Neurosci. 16, 551–563 (2015).
62. Miyoshi, G., Butt, S. J., Takebayashi, H. & Fishell, G. Physiologically distinct
temporal cohorts of cortical interneurons arise from telencephalic Olig2-
expressing precursors. J. Neurosci. 27, 7786–7798 (2007).
63. Peixoto, R. T., Wang, W., Croney, D. M., Kozorovitskiy, Y. & Sabatini, B. L.
Early hyperactivity and precocious maturation of corticostriatal circuits in
Shank3B(-/-) mice. Nat. Neurosci. 19, 716–724 (2016).
64. Miyoshi, G. Elucidating the developmental trajectories of GABAergic cortical
interneuron subtypes. Neurosci. Res. 138, 26–32 (2019).
65. Pancrazi, L. et al. Foxg1 localizes to mitochondria and coordinates cell
differentiation and bioenergetics. Proc. Natl Acad. Sci. USA 112, 13910–13915
(2015).
66. Hollis, F., Kanellopoulos, A. K. & Bagni, C. Mitochondrial dysfunction in
autism spectrum disorder: clinical features and perspectives. Curr. Opin.
Neurobiol. 45, 178–187 (2017).
67. Siddiqui, M. F., Elwell, C. & Johnson, M. H. Mitochondrial dysfunction in
autism spectrum disorders. Autism Open Access 6, 1000190 (2016).
68. Chen, L. et al. MeCP2 binds to non-CG methylated DNA as neurons mature,
influencing transcription and the timing of onset for Rett syndrome. Proc.
Natl Acad. Sci. USA 112, 5509–5514 (2015).
69. Gabel, H. W. et al. Disruption of DNA-methylation-dependent long gene
repression in Rett syndrome. Nature 522, 89–93 (2015).
70. Katayama, Y. et al. CHD8 haploinsufficiency results in autistic-like
phenotypes in mice. Nature 537, 675–679 (2016).
71. Wade, A. A., Lim, K., Catta-Preta, R. & Nord, A. S. Common CHD8 genomic
targets contrast with model-specific transcriptional impacts of CHD8
haploinsufficiency. Fron. Mol. Neurosci. 11, 481 (2019).
72. Zoghbi, H. Y. Rett syndrome and the ongoing legacy of close clinical
observation. Cell 167, 293–297 (2016).
73. Dastidar, S. G. et al. Isoform-specific toxicity of Mecp2 in postmitotic neurons:
suppression of neurotoxicity by FoxG1. J. Neurosci. 32, 2846–2855 (2012).
74. Ma, M., Adams, H. R., Seltzer, L. E., Dobyns, W. B. & Paciorkowski, A. R.
Phenotype differentiation of FOXG1 and MECP2 disorders: a new method for
characterization of developmental encephalopathies. J. Pediatr. 178, 233–240
(2016). e210.
75. Bicks, L. K. et al. Prefrontal parvalbumin interneurons require juvenile social
experience to establish adult social behavior. Nat. Commun. 11, 1003 (2020).
76. Miyamae, T., Chen, K., Lewis, D. A. & Gonzalez-Burgos, G. Distinct
physiological maturation of parvalbumin-positive neuron subtypes in mouse
prefrontal cortex. J. Neurosci. 37, 4883–4902 (2017).
77. Del Pino, I., Rico, B. & Marin, O. Neural circuit dysfunction in mouse models
of neurodevelopmental disorders. Curr. Opin. Neurobiol. 48, 174–182 (2018).
78. Wang, L. et al. Restricted expression of mutant SOD1 in spinal motor neurons and
interneurons induces motor neuron pathology. Neurobiol. Dis. 29, 400–408 (2008).
79. Hanashima, C., Shen, L., Li, S. C. & Lai, E. Brain factor-1 controls the
proliferation and differentiation of neocortical progenitor cells through
independent mechanisms. J. Neurosci. 22, 6526–6536 (2002).
80. Mayer, C. et al. Developmental diversification of cortical inhibitory
interneurons. Nature 555, 457–462 (2018).
81. Sousa, V. H., Miyoshi, G., Hjerling-Leffler, J., Karayannis, T. & Fishell, G.
Characterization of Nkx6-2-derived neocortical interneuron lineages. Cereb.
Cortex 19, i1–i10 (2009). Suppl 1.
82. Franklin, K. B. & Paxinos, G. The mouse brain in stereotaxic coordinates
(Academic press, 2008).
83. Tobler, I., Deboer, T. & Fischer, M. Sleep and sleep regulation in normal and
prion protein-deficient mice. J. Neurosci. 17, 1869–1879 (1997).
Acknowledgements
We thank the following Drs. for kindly sharing their reagents with us: Eseng Lai (FoxG1-
LacZ knock-in mutant), Carina Hanashima (TRE-FoxG1 transgenic), Marc Ekker (Dlx5a-
Cre transgenic), and Klaus-Armin Nave (Nex-Cre knock-in). We also wish to thank Drs.
Kazutaka Ikeda and Hiroko Kotajima for helpful inputs regarding mouse behavioral assays
and Dr. Mitsuharu Midorikawa for help with photo acquisition. We thank Mai Hatakenaka,
Emiko Naraba, Tomoya Tsuchida, Sachie Sekino, Fumiya Urata and Yumi Tani for tech-
nical help. We greatly appreciate Takanori Maeda and Junnosuke Ohnuma for the effort in
mouse behavioral analysis. We also thank Dr. Tomomi Shimogori for critically reading this
manuscript prior to submission. We are grateful for the communications with Japan and
international FOXG1 family communities. This work was supported by Grants-in-Aid for
Scientific Research JP17H05775, JP17K07102, JP19H04789, JP19H05228, and JP20K07362
(G.M.), JP15H01667, JP19H03343, JP20H05481 and JP20H05916 (M.M.), and NIH grant
R01MH095147 (G.F.). G.M. is supported by the Believe in a Cure, Inc., Mochida Memorial
Foundation for Medical and Pharmaceutical Research, Cell Science Research Foundation,
Takeda Science Foundation, and Brain Science Foundation.
Author contributions
conceptualization (G.M. and R.M.), project administration and supervision (G.M. and M.
M.), data curation, formal analysis, investigation and methodology (G.M., Y.U., A.N., K.
H., H.O., Y. Yagasaki, and Y.K.), funding acquisition and resources (G.M., Y. Yanagawa,
G.F., and M.M.), software (G.M., Y.U., A.N., and H.O.), validation and visualization (G.
M., Y.U., A.N., K.H., and R.M.), writing original draft (G.M. and R.M.) and editing (G.
M., G.F., R.M., and M.M.).
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s41467-021-23987-z.
Correspondence and requests for materials should be addressed to G.M.
Peer review information Nature Communications thanks Takanobu Nakazawa,
Zhengping Jia and the other anonymous reviewer(s) for their contribution to the peer
review of this work. Peer reviewer reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23987-z
16 NATURE COMMUNICATIONS |         (2021) 12:3773 | https://doi.org/10.1038/s41467-021-23987-z | www.nature.com/naturecommunications
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2021
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23987-z ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:3773 | https://doi.org/10.1038/s41467-021-23987-z | www.nature.com/naturecommunications 17
